Trial Profile
Study of pazopanib in non-clear cell renal carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 11 Aug 2016 New trial record